AMN Healthcare shows massive 302% revenue growth but concerning operational performance with continued significant losses and declining gross profit margins.
The dramatic revenue increase suggests major business expansion, likely through acquisition, but the company remains unprofitable with operating losses of $55.5M and declining gross margins from prior year. The combination of massive growth with persistent losses and margin compression indicates potential integration challenges or unsustainable pricing in the expanded business model.
AMN's financials show explosive revenue growth of 302% to $2.0B, but this came at the cost of profitability as gross profit declined 15.8% to $774.1M, indicating severe margin compression. While operating and net losses improved in absolute terms, the company remains significantly unprofitable with $55.5M in operating losses, and debt reduction of 27% to $767.1M suggests either forced deleveraging or asset sales. The overall picture suggests a company that has rapidly expanded through acquisition but is struggling to achieve operational efficiency and profitability at scale.
Strong top-line growth of 302.2% — accelerating demand or successful expansion into new markets.
Cash position surged 219% — strong cash generation or capital raise providing significant financial cushion.
Capex reduced 56% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Net income grew 34.9% — bottom-line growth signals improving overall business health.
Interest expense surged 34% — significant debt increase or rising rates materially impacting earnings.
Debt reduced 27.4% — deleveraging strengthens balance sheet and reduces financial risk.
Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Liabilities reduced 15% — deleveraging improves balance sheet strength and financial flexibility.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →